INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit | MicrobiomeTrials← Back to trialsNCT04804072
INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit
CompletedNAINTERVENTIONAL
Trial Details
Start: 2021-06-02Est. Completion: 2024-12-17
Enrollment target: 447 participants Locations- UCLA Vine Street Clinic, Los Angeles, California, United States
- George Washington University CRS, Washington D.C., District of Columbia, United States
- Bronx Prevention Center CRS, The Bronx, New York, United States
- Penn Prevention CRS, Philadelphia, Pennsylvania, United States
- Houston AIDS Research Team CRS, Houston, Texas, United States
Other microbiome trials you might be interested in
HIV InfectionsAdherence, Medication
The investigators will implement a 24-month fractional factorial design study (Aim 1). The investigators will recruit 51…
Cape Town, South AfricaEst. completion May 28, 2026
HIV-1-infection
The goal of this clinical study is to provide continued access to the study drug(s) to children and adolescents with hum…
Buenos Aires, ArgentinaEst. completion Mar 2034
Recruiting
Substance Use DisordersHIV Infections
This is a multi-phased study, funded through a National Institute on Drug Abuse (NIDA) K24 grant that aims to ultimately…
Charleston, United StatesEst. completion Aug 31, 2026